Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coffey

Showing results (451-460 of 512) with videos related to

Pageof 52
Sort By:
Journal of Parkinson'S Disease|September 25, 2018
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)Lana M Chahine, Thomas G Beach, Nicholas Seedorff, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Annals of Clinical and Translational Neurology|April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseDaniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Journal of the American Medical Informatics Association : JAMIA|November 9, 2020
Unveiling the silent threat among us: leveraging health information technology in the search for asymptomatic COVID 19 healthcare workersJon W McKeeby, Christopher M Siwy, Josanne Revoir, et al.
Annals of Neurology|May 7, 2026
How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein DiseaseTanya Simuni, Christopher S Coffey, Catherine M Kopil, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Pageof 52

Showing results (451-460 of 512) with videos related to

Sort By:
Pageof 52
Journal of Parkinson'S Disease|September 25, 2018
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)Lana M Chahine, Thomas G Beach, Nicholas Seedorff, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.
Annals of Clinical and Translational Neurology|April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseDaniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Journal of the American Medical Informatics Association : JAMIA|November 9, 2020
Unveiling the silent threat among us: leveraging health information technology in the search for asymptomatic COVID 19 healthcare workersJon W McKeeby, Christopher M Siwy, Josanne Revoir, et al.
Annals of Neurology|May 7, 2026
How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein DiseaseTanya Simuni, Christopher S Coffey, Catherine M Kopil, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Pageof 52